GeneTex

  • Country / Location Selection

United States (US)

Zika virus Envelope protein antibody

Orthogonal
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

Cat. No. GTX133314

Reference 85
14

Host

 Rabbit

Clonality

 Polyclonal

Isotype

 IgG

Application

 WB, ICC/IF, IHC-P

Reactivity

 Zika virus
Package
100 μl ($399),
25 μl ($169)
See all Zika virus Envelope protein products

APPLICATION

Application Note

*Optimal dilutions/concentrations should be determined by the researcher.
Application Recommended Dilution
WB 1:500-1:3000
ICC/IF 1:100-1:1000
IHC-P Assay dependent
Not tested in other applications.

Calculated MW

54 kDa. ( Note )

Positive Control

Zika virus Envelope-transfected 293T

PROPERTIES

Form

Liquid

Buffer

1XPBS (pH7), 1% BSA, 20% Glycerol

Preservative

0.025% ProClin 300

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.

Concentration

0.45 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Zika virus

Immunogen

Carrier-protein conjugated synthetic peptide encompassing a sequence within the center region of Zika virus Envelope protein (Zika virus (strain H/PF/2013)). The exact sequence is proprietary.

Purification

Purified by antigen-affinity chromatography.

Conjugation

Unconjugated

RRID

AB_2747413

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.

TARGET

Synonyms

Zika virus Envelope , ZIKV Envelope

Research Area

DATA IMAGES

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Mock and infected Vero and BHK-21 whole cell extracts (20 μg) were separated by gradient gel, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of Zika Virus-PRVABC59 infected (A) and non-infected (B) vero cells using Zika virus Envelope protein antibody (GTX133314).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-infected (–) and infected (+) C6/36 whole cell extracts (30 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-transfected (–) and transfected (+) 293T whole cell extracts (60 μg) were separated by 10% SDS-PAGE, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:5000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of arboviruses infected cells using Zika virus Envelope protein antibody (GTX133314).
Samples: EUROIMMUN Arboviral Fever Mosaic 2 slide (FR 2668-1010-1).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:500.
Blue: Hoechst 33342 staining.
Scale bar = 10 μm.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of non-infected and infected vero or BHK-21 cells using Zika virus Envelope protein antibody (GTX133314).
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:4000.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314

GTX133314 WB Image

Non-infected (–) and infected (+) vero cells (15 μg) were separated by gradient gel, and the membrane was blotted with Zika virus Envelope protein antibody (GTX133314) diluted at 1:2000. The HRP-conjugated anti-rabbit IgG antibody (GTX213110-01) was used to detect the primary antibody.
This image was provided courtesy of cooperative research laboratories.

Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314

GTX133314 ICC/IF Image

Immunofluorescent analysis of Zika virus infected cells using Zika virus NS5 protein antibody (GTX133314).
Sample: Mock and zika virus-infected cells.
Green: Zika virus Envelope protein antibody (GTX133314) diluted at 1:100.

REFERENCE

Application Reference

Gilbert-Jaramillo J et al. Biol Open 2023; 12 (4) Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy.
Lin DC et al. Parasit Vectors 2023; 16 (1) : 160 Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
Chen T et al. Virol Sin 2023; 38 (2) : 222-232 Splicing factor SF3B3, a NS5-binding protein, restricts ZIKV infection by targeting GCH1.
Pan P et al. Signal Transduct Target Ther 2023; 8 (1) : 194 SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication.
Chen W et al. Virol Sin 2023; 38 (1) : 23-33 Zika virus non-structural protein 4B interacts with DHCR7 to facilitate viral infection.
Application : WB
Show More +
Submit a Reference

REVIEW

Zika virus Envelope protein antibody Cat. No. GTX133314

Rating
( Average 4.9 based on 14 users reviews)
Application
Western Blot(WB)
( Average 4.9 based on 11 users reviews)
Immunocytochemistry/ Immunofluorescence(ICC/IF)
( Average 5 based on 3 users reviews)
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 03-Oct-2022
Score :
Application Tested : WB
Figure Note : The data was peer reviewed and published in the 2022 in Viruses. PMID: 35215967
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 10-Aug-2021
Score :
Application Tested : WB
Figure Note : The data was peer reviewed and published in the journal MBio in 2018.PMID: 30401782
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 10-Aug-2021
Score :
Application Tested : WB
Figure Note : The data was peer reviewed and published in the journal PLoS Negl Trop Dis in 2017.PMID: 28481898
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 18-Mar-2021
Score :
Application Tested : WB
Figure Note : The data was peer reviewed and published in the journal mBio in 2017. PMID: 28698279
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 18-Mar-2021
Score :
Application Tested : WB
Sample Species : ZIKV
Figure Note : The data was peer reviewed and published in the journal Front Pharmacol in 2019. PMID: 31249527
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 18-Mar-2021
Score :
Application Tested : WB
Sample Species : ZIKV
Figure Note : The data was peer reviewed and published in the journal Front Pharmacol in 2019. PMID: 31249527
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 18-Mar-2021
Score :
Application Tested : WB
Sample Species : ZIKV
Figure Note : The data was peer reviewed and published in the journal Front Microbiol in 2019. PMID: 30984137
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 18-Mar-2021
Score :
Application Tested : WB
Sample Species : ZIKV
Figure Note : The data was peer reviewed and published in the journal Emerg Microbes Infect in 2019. PMID: 30866755
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 03-Apr-2018
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : Zika Virus-MR-766 infected BHK-21 cells
Fixation : 4% paraformaldehyde, 0.5Hr
Permeabilization /Antigen retrieval : 0.1% Triton X-100, 4°C, 2 hrHr
Primary Antibody : 1:3000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 14-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : ZIKV-infected vero cells, ZIKV-infected BHK21 cells
Blocking : 5% non-fat milk
Primary Antibody : 1:4000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 13-Jun-2016
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : ZIKV-infected vero cells, ZIKV-infected BHK21 cells
Blocking : 3% BSA in PBS
Primary Antibody : 1:4000, 4°C, 16Hr
Anti-Zika virus Envelope protein antibody used in Immunocytochemistry/ Immunofluorescence (ICC/IF). GTX133314
Date : Anonymous submitted on 04-Jun-2016
Score :
Application Tested : ICC/IF
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected vero cells
Fixation : methanol + acetone
Primary Antibody : 1:4000, 4°C, 16Hr
Figure Note : A: Zika Virus-PRVABC59 infected vero cells. (MOI=1 24h), B: vero cell
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 04-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected C6/36 cells
Amount used : 20μg
Blocking : 5% non-fat milk
Primary Antibody : 1:4000, 4°C, 16Hr
Lane Description : Lane 1: C6/36 cells, Lane 2: Zika Virus-PRVABC59 infected C6/36 cells
Anti-Zika virus Envelope protein antibody used in Western Blot (WB). GTX133314
Date : Anonymous submitted on 02-Jun-2016
Score :
Application Tested : WB
Sample Species : ZIKV
Sample : Zika Virus-PRVABC59 infected vero cells
Amount used : 15μg
Blocking : 5% non-fat milk, 25°C, 0.5Hr
Primary Antibody : 1:2000, 4°C, 16Hr
Lane Description : Lane 1: vero cells, Lane 2: Zika Virus-PRVABC59 infected vero cells. (MOI=0.1 96h)
Show More +
Submit a Review
Application Reference
Gilbert-Jaramillo J et al. Biol Open 2023; 12 (4) Zika virus-induces metabolic alterations in fetal neuronal progenitors that could influence in neurodevelopment during early pregnancy.
Lin DC et al. Parasit Vectors 2023; 16 (1):160 Co-infection of dengue and Zika viruses mutually enhances viral replication in the mosquito Aedes aegypti.
Chen T et al. Virol Sin 2023; 38 (2):222-232 Splicing factor SF3B3, a NS5-binding protein, restricts ZIKV infection by targeting GCH1.
Pan P et al. Signal Transduct Target Ther 2023; 8 (1):194 SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication.
Hu D et al. Viruses 2023; 15 (1) ZDHHC11 Suppresses Zika Virus Infections by Palmitoylating the Envelope Protein.
Fu Y et al. PLoS Pathog 2023; 19 (1):e1011090 Exosomes mediate Coxsackievirus B3 transmission and expand the viral tropism.
Application : WB
Chen W et al. Virol Sin 2023; 38 (1):23-33 Zika virus non-structural protein 4B interacts with DHCR7 to facilitate viral infection.
Application : WB
Lima MLD et al. Braz J Microbiol 2022; 53 (3):1279-1287 Early infection of Zika virus in the male reproductive system of AG129 mice: molecular and immunohistochemical evaluation.
Polonio CM et al. Int J Mol Sci 2022; 23 (18) microRNAs Control Antiviral Immune Response, Cell Death and Chemotaxis Pathways in Human Neuronal Precursor Cells (NPCs) during Zika Virus Infection.
Application : ICC/IF
Wang J et al. J Biol Chem 2022; 298 (10):102471 A cathelicidin antimicrobial peptide from Hydrophis cyanocinctus inhibits Zika virus infection by downregulating expression of a viral entry factor.
Huang Y et al. Virol Sin 2022; 37 (6):904-912 A novel IFNbeta-induced long non-coding RNA ZAP-IT1 interrupts Zika virus replication in A549 cells.
Rangel MV et al. J Virol 2022; 96 (2):e0177421 Structurally Conserved Domains between Flavivirus and Alphavirus Fusion Glycoproteins Contribute to Replication and Infectious-Virion Production.
Wikan N et al. Pharmaceutics 2022; 14 (12) Alpinetin Suppresses Zika Virus-Induced Interleukin-1β Production and Secretion in Human Macrophages.
Gao SS et al. iScience 2022; 25 (12):105481 GPI-anchored ligand-BioID2-tagging system identifies Galectin-1 mediating Zika virus entry.
Zhou S et al. Virol Sin 2022; 37 (5):685-694 Rottlerin plays an antiviral role at early and late steps of Zika virus infection.
Watts JL et al. Development 2022; 149 (14) The fetal lineage is susceptible to Zika virus infection within days of fertilization.
Rui Zhou et al. Bioorg Chem. 2022; 128 Repurposing of the antihistamine mebhydrolin napadisylate for treatment of Zika virus infection
Application : WB
Reactivity : Zika virus
Mahamud-Ur Rashid et al. Viruses 2022; 14 (2) Zika Virus Infection of Sertoli Cells Alters Protein Expression Involved in Activated Immune and Antiviral Response Pathways, Carbohydrate Metabolism and Cardiovascular Disease.
Application : WB
Frias IAM et al. ACS Appl Mater Interfaces 2022; 14 (1):41-48 Self-Enriching Electrospun Biosensors for Impedimetric Sensing of Zika Virus.
Jia Quan et al. Virol Sin 2021; 36 (5):1165-1176 Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses.
Application : WB
Xi Yu et al. Proc Natl Acad Sci U S A 2021; 118 (42) A mutation-mediated evolutionary adaptation of Zika virus in mosquito and mammalian host.
Application : WB
Philma Glora Muthuraj et al. Cell Death Discov 2021; 7 (1):24 Zika virus infection induces endoplasmic reticulum stress and apoptosis in placental trophoblasts.
Application : WB, ICC/IF
Hongli Jin et al. PLoS Negl Trop Dis 2021; 15 (6):e0009484 An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens.
Application : WB, ICC/IF
Dingwen Hu et al. Virulence 2021; 12 (1):1795-1807 LAMR1 restricts Zika virus infection by attenuating the envelope protein ubiquitination.
Application : WB, ICC/IF
Yingchong Wang et al. Viruses 2021; 13 (10) USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination.
Application : WB
Zhang JW et al. Virol Sin 2021; 36 (3):476-489 Generation of A Stable GFP-reporter Zika Virus System for High-throughput Screening of Zika Virus Inhibitors.
Lu JW et al. Antiviral Res 2021; 195:105188 Synergistic in-vitro antiviral effects of combination treatment using anidulafungin and T-1105 against Zika virus infection.
Porier DL et al. Vaccines (Basel) 2021; 9 (10) Enemy of My Enemy: A Novel Insect-Specific Flavivirus Offers a Promising Platform for a Zika Virus Vaccine.
Application : WB
Wang Y. et al. biochemistry 2021; (Epub) USP38 Inhibits Zika Virus Infection by Removing Envelope Protein Ubiquitination.
Gao J et al. Virol J 2021; 18 (1):151 Construction of an infectious clone of Zika virus stably expressing an EGFP marker in a eukaryotic expression system.
Application : WB
Mladinich MC et al. mBio 2021; 12 (4):e0196221 Blockade of Autocrine CCL5 Responses Inhibits Zika Virus Persistence and Spread in Human Brain Microvascular Endothelial Cells.
Application : WB
Singh S et al. Biomolecules 2021; 11 (5) Povidone-Iodine Attenuates Viral Replication in Ocular Cells: Implications for Ocular Transmission of RNA Viruses.
Application : ICC/IF
Jasperse B et al. Sci Rep 2021; 11 (1):6492 Single dose of a replication-defective vaccinia virus expressing Zika virus-like particles is protective in mice.
Shin HJ et al. Microorganisms 2021; 9 (3) Structure-Based Virtual Screening: Identification of a Novel NS2B-NS3 Protease Inhibitor with Potent Antiviral Activity against Zika and Dengue Viruses.
Application : WB
Oh SJ et al. Cells 2021; 10 (3) SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Application : WB
Huang L et al. Cell Biol Toxicol 2021; High-content screening of diterpenoids from Isodon species as autophagy modulators and the functional study of their antiviral activities.
Application : WB
Khongwichit S et al. Sci Rep 2021; 11 (1):393 A functional interaction between GRP78 and Zika virus E protein.
Application : WB
Drouin A et al. Cytokine 2021; 137:155342 Impact of Zika virus on the human type I interferon osteoimmune response.
Application : IHC-P
Kabir MA et al. Sci Rep 2020; 10 (1):11906 An antibody panel for highly specific detection and differentiation of Zika virus.
Clark AE et al. J Virol 2020; (Epub) Zika virus is transmitted in neural progenitor cells via cell-to-cell spread and infection is inhibited by the autophagy inducer trehalose.
Application : WB
Sun F et al. Viruses 2020; 12 (3) Topology, Antiviral Functional Residues and Mechanism of IFITM1.
Lingel A et al. J Biol Chem 2020; 295 (50):17114-17127 Amyloid precursor protein is a restriction factor that protects against Zika virus infection in mammalian brains.
Application : ICC/IF
Huang Y et al. J Virol 2020; 94 (23) Inositol-Requiring Enzyme 1α Promotes Zika Virus Infection through Regulation of Stearoyl Coenzyme A Desaturase 1-Mediated Lipid Metabolism.
Application : WB
Srivastava M et al. Nat Commun 2020; 11 (1):3896 Chemical proteomics tracks virus entry and uncovers NCAM1 as Zika virus receptor.
Application : WB
Zeng J et al. Cell Stem Cell 2020; 27 (4):618-632.e9 The Zika Virus Capsid Disrupts Corticogenesis by Suppressing Dicer Activity and miRNA Biogenesis.
Application : WB
Botwina P et al. Viruses 2020; 12 (9) In Vitro Inhibition of Zika Virus Replication with Poly(Sodium 4-Styrenesulfonate).
Application : ICC/IF
Chen J et al. mBio 2020; 11 (5) Placental Alkaline Phosphatase Promotes Zika Virus Replication by Stabilizing Viral Proteins through BIP.
Application : ICC/IF
Jia He et al. Autophagy 2020; (Epub) Zika virus NS2A protein induces the degradation of KPNA2 (karyopherin subunit alpha 2) via chaperone-mediated autophagy.
Application : WB
Chen H et al. Virology 2020; 546:88-97 Antiviral activity of lycorine against Zika virus in vivo and in vitro.
Application : WB
Wu Y et al. PLoS Negl Trop Dis 2020; 14 (3):e0008083 C19orf66 interrupts Zika virus replication by inducing lysosomal degradation of viral NS3.
Application : WB
Garg H et al. Sci Rep 2020; 10 (1):4017 Virus Like Particles (VLP) as multivalent vaccine candidate against Chikungunya, Japanese Encephalitis, Yellow Fever and Zika Virus.
Application : WB
Chiu CF et al. Front Microbiol 2020; 11:214 The Mechanism of the Zika Virus Crossing the Placental Barrier and the Blood-Brain Barrier.
Application : WB, ICC/IF
Li C et al. Antimicrob Agents Chemother 2019; (Epub) Azithromycin Protects against Zika virus Infection by Upregulating virus-induced Type I and III Interferon Responses.
Lin JY et al. Stem Cell Res Ther 2019; 10 (1):387 Activation of type I interferon antiviral response in human neural stem cells.
Application : ICC/IF
Lu CY et al. Viruses 2019; 11 (11) The Rescue and Characterization of Recombinant, Microcephaly-Associated Zika Viruses as Single-Round Infectious Particles.
Application : WB
Pujhari S et al. Emerg Microbes Infect 2019; 8 (1):8-16 Heat shock protein 70 (Hsp70) mediates Zika virus entry, replication, and egress from host cells.
Strange DP et al. MBio 2019; 10 (4) Axl Promotes Zika Virus Entry and Modulates the Antiviral State of Human Sertoli Cells.
Khaiboullina S et al. Front Pharmacol 2019; 10:642 Transcriptome Profiling Reveals Pro-Inflammatory Cytokines and Matrix Metalloproteinase Activation in Zika Virus Infected Human Umbilical Vein Endothelial Cells.
Chuang FK et al. Antimicrob Agents Chemother 2019; (Epub) Anti-inflammatory compound shows therapeutic safety and efficacy against flavivirus infection.
Application : WB
Routhu NK et al. Int J Mol Sci 2019; 20 (20) Glycosylation of Zika Virus is Important in Host-Virus Interaction and Pathogenic Potential.
Zhang X et al. MBio 2019; 10 (5) Zika Virus NS2A-Mediated Virion Assembly.
Application : WB, ICC/IF
Garg H et al. Vaccine 2019; Capsid containing virus like particle vaccine against Zika virus made from a stable cell line.
Application : WB
Sher AA et al. Front Microbiol 2019; 10:596 Zika Virus Infection Disrupts Astrocytic Proteins Involved in Synapse Control and Axon Guidance.
Application : WB
Ojha CR et al. PLoS One 2019; 14 (2):e0208543 Toll-like receptor 3 regulates Zika virus infection and associated host inflammatory response in primary human astrocytes.
Application : ICC/IF
Taguwa S et al. Cell Rep 2019; 26 (4):906-920.e3 Zika Virus Dependence on Host Hsp70 Provides a Protective Strategy against Infection and Disease.
Application : WB, ICC/IF
Li F et al. J Biol Chem 2019; 294 (1):182-194 A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles.
Application : WB
Tangsongcharoen C et al. Biochim Biophys Acta Proteins Proteom 2019; 1867 (2):89-97 Analysis of cellular proteome changes in response to ZIKV NS2B-NS3 protease expression.
Application : WB
Fontaine KA et al. MBio 2018; 9 (6) The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid Protein.
Application : WB
Li P et al. Cell Host Microbe 2018; 24 (6):875-886.e5 Integrative Analysis of Zika Virus Genome RNA Structure Reveals Critical Determinants of Viral Infectivity.
Application : WB
N?rnberger C et al. J Virol 2018; (Epub) A measles virus-based vaccine candidate mediates protection against Zika virus in an allogenic mouse pregnancy model.
Application : WB
Khachatoorian R et al. Virology 2018; 522:228-233 HSP70 Copurifies with Zika Virus Particles.
Application : WB
Mazar J et al. PLoS One 2018; 13 (7):e0200358 Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.
Application : WB, ICC/IF
Routhu NK et al. Mol Pharm 2018; (Epub) Polymeric Prodrugs Targeting Polyamine Metabolism Inhibit Zika Virus Replication.
Application : ICC/IF
Chambers MT et al. J Virol 2018; (Epub) Probing Zika virus neutralization determinants with glycoprotein mutants bearing linear epitope insertions.
Application : WB
Huang Y et al. Cell Discov 2018; 4:19 Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869.
Application : WB
Wichgers Schreur PJ et al. Emerg Microbes Infect 2018; 7 (1):42 Microencephaly in fetal piglets following in utero inoculation of Zika virus.
Application : ICC/IF
Fontaine K.A. et al. bioRxiv 2018; (Epub) The cellular NMD pathway restricts Zika virus infection and is targeted by the viral capsid protein.
Application : WB
Jin L et al. Nat Immunol 2018; (Epub) Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor.
Application : WB
Boigard H et al. PLoS Negl Trop Dis 2017; 11 (5):e0005608 Zika virus-like particle (VLP) based vaccine.
Tabata T et al. J Infect Dis 2017; (Epub) Zika Virus Replicates in Proliferating Cells in Explants from First-trimester Human Placentas, Potential Sites for Dissemination of Infection.
Garg H et al. J Virol 2017; (Epub) Development of Virus like Particle Vaccine and Reporter Assay for Zika Virus.
Application : WB
Mladinich MC et al. MBio 2017; 8 (4) Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
Application : WB
Estoppey D et al. Cell Rep 2017; 19 (3):451-460 The Natural Product Cavinafungin Selectively Interferes with Zika and Dengue Virus Replication by Inhibition of the Host Signal Peptidase.
Application : WB
Chahal JS et al. Sci Rep 2017; 7 (1):252 An RNA nanoparticle vaccine against Zika virus elicits antibody and CD8+ T cell responses in a mouse model.
Application : WB
Boigard H et al. PLoS Negl Trop Dis 2017; (Epub) Zika virus-like particle (VLP) based vaccine.
Application : WB
SDS
PBS.pdf
Glycerol.pdf
Proclin.pdf
Package List Price ($)
$ 399
$ 169